Search research articles
Contact Us
Filters
Showing results (31-40 of 1,157) with videos related to
Page
of 116
Sort By:
Cell Metabolism
|
April 9, 2013
The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders
Cristoforo Silvestri, Vincenzo Di Marzo
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 5, 2010
FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels
Stefania Petrosino, Vincenzo Di Marzo
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 15, 2015
The Endocannabinoid System and its Modulation by Phytocannabinoids
Vincenzo Di Marzo, Fabiana Piscitelli
Current Opinion in Lipidology
|
March 14, 2007
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo, Stefania Petrosino
Journal of Endocrinological Investigation
|
June 6, 2006
Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance
I Matias, V Di Marzo
CNS & Neurological Disorders Drug Targets
|
July 17, 2010
Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders
Tiziana Bisogno, Vincenzo Di Marzo
Trends in Pharmacological Sciences
|
April 9, 2008
FAAH and anandamide: is 2-AG really the odd one out?
Vincenzo Di Marzo, Mauro Maccarrone
Expert Opinion on Investigational Drugs
|
July 12, 2012
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri, Vincenzo Di Marzo
Nature Neuroscience
|
April 28, 2005
Endocannabinoid control of food intake and energy balance
Vincenzo Di Marzo, Isabel Matias
Recenti Progressi in Medicina
|
May 2, 2003
[The endocannabinoid system as a target for the development of new drugs for cancer therapy]
Maurizio Bifulco, Vincenzo Di Marzo
Page
of 116
Search research articles
Search
Showing results (31-40 of 1,157) with videos related to
Sort By:
Page
of 116
Cell Metabolism
|
April 9, 2013
The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders
Cristoforo Silvestri, Vincenzo Di Marzo
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 5, 2010
FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels
Stefania Petrosino, Vincenzo Di Marzo
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 15, 2015
The Endocannabinoid System and its Modulation by Phytocannabinoids
Vincenzo Di Marzo, Fabiana Piscitelli
Current Opinion in Lipidology
|
March 14, 2007
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo, Stefania Petrosino
Journal of Endocrinological Investigation
|
June 6, 2006
Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance
I Matias, V Di Marzo
CNS & Neurological Disorders Drug Targets
|
July 17, 2010
Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders
Tiziana Bisogno, Vincenzo Di Marzo
Trends in Pharmacological Sciences
|
April 9, 2008
FAAH and anandamide: is 2-AG really the odd one out?
Vincenzo Di Marzo, Mauro Maccarrone
Expert Opinion on Investigational Drugs
|
July 12, 2012
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri, Vincenzo Di Marzo
Nature Neuroscience
|
April 28, 2005
Endocannabinoid control of food intake and energy balance
Vincenzo Di Marzo, Isabel Matias
Recenti Progressi in Medicina
|
May 2, 2003
[The endocannabinoid system as a target for the development of new drugs for cancer therapy]
Maurizio Bifulco, Vincenzo Di Marzo
Page
of 116